Metronidazol Ratiopharm (Metronidazole)

Metronidazole is taken up by anaerobic microbes and reduced by their cellular proteins, forming reactive nitro radicals. These radicals damage DNA, inhibit nucleic acid synthesis and ultimately cause cell death, selectively affecting anaerobic bacteria and certain protozoa while sparing most human cells.

The specific dose and treatment duration are determined by the prescribing clinician based on the infection type, severity, patient weight, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of metronidazole in pregnancy is not fully established; it is generally avoided in the first trimester and used only when the benefits outweigh potential risks. Breastfeeding mothers should consult their healthcare provider, as small amounts may be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metronidazole is a nitroimidazole, offering broad activity against anaerobic bacteria and protozoa, whereas alternatives such as tinidazole or ornidazole have similar mechanisms but differ in dosing frequency and side‑effect profiles. Choice of therapy depends on infection type, resistance patterns and patient tolerance.

Store the tablets at room temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Do not refrigerate or freeze the product, and keep it out of reach of children.

Metronidazol Ratiopharm is taken orally with a full glass of water. It may be taken with or without food, but taking it with meals can reduce gastrointestinal upset. The tablet should be swallowed whole and not chewed or crushed unless instructed by a healthcare professional.

Serious adverse events include seizures, peripheral neuropathy, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, liver toxicity and blood dyscrasias like neutropenia. Patients should seek immediate medical attention if they experience neurological symptoms, rash, jaundice or unexplained bleeding.

Individuals with a known hypersensitivity to metronidazole or other nitroimidazoles should avoid the drug. Patients with severe hepatic impairment, those taking disulfiram, or those with a history of seizures should discuss alternatives with their clinician before starting therapy.